Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hyperglycemia 1 endocrinologydiseases
hyperlipidemia 2 endocrinologydiseases
complications of diabetes mellitus 1 endocrinologydiseases
diabetes mellitus 1 endocrinologydiseases
diabetic retinopathy 7 endocrinologydiseases
fenofibrate 8 endocrinologydiseasesdrugs

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
fenofibrate 1817 In addition, whether serum lipids involved in the progression of DR were relatively unexplored, but fenofibrate was confirmed to benefit the DR cases.Conclusions:Based on recent published data, we did not find obvious
fenofibrate 16566 future.Although the relationship between serum lipids and DR progression remained inconclusive, the fenofibrate was confirmed to benefit the DR cases[[37],[38]] the Fenofibrate Intervention and Event Lowering in
fenofibrate 16725 cases[[37],[38]] the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study[[38]] demonstrated that fenofibrate could prevent the progression of DR without significantly changing the serum lipids levels, and the
fenofibrate 17142 Diabetes (ACCORD) Eye study[[37]] observed comparable effects of controlling DR progression between fenofibrate treatment and the intensive treatment of glycemia. Thus, the fenofibrate treatment should be strongly
fenofibrate 17215 controlling DR progression between fenofibrate treatment and the intensive treatment of glycemia. Thus, the fenofibrate treatment should be strongly recommended for the DR cases, and the exact mechanisms of how fenofibrate
fenofibrate 17318 fenofibrate treatment should be strongly recommended for the DR cases, and the exact mechanisms of how fenofibrate functioned should be further investigated as well.Study strengths and limitations4.1For decades, multiple
fenofibrate 18499 addition, whether any association existed between serum lipids and DR progression was unknown, but the fenofibrate treatment should be recommended since it could prevent the DR progression through lipid-modulating independent
fenofibrate 18795 needed to further investigate the association between serum lipids and DR. As well, the mechanisms of fenofibrate involved in the control of DR progression needed further investigation.Author contributionsData curation:
Select Disease Character Offset Disease Term Instance
complications of diabetes mellitus 2161 observed in the DR cases.Introduction1Diabetic retinopathy (DR), one of the most common microvascular complications of diabetes mellitus (DM), was the foremost cause of blindness in the working age group.[[1]] Except for the damaging effects
diabetes mellitus 2178 cases.Introduction1Diabetic retinopathy (DR), one of the most common microvascular complications of diabetes mellitus (DM), was the foremost cause of blindness in the working age group.[[1]] Except for the damaging effects
diabetic retinopathy 53 Title: MedicineRelationship between dyslipidemia and diabetic retinopathy A systematic review and meta-analysisYue ZhouChangyun WangKe ShiXiaolong YinStefano Omboni.aThe Children's
diabetic retinopathy 453 9/2018Publication date (epub): 9/2018AbstractAbstractBackground:The association between serum lipids and diabetic retinopathy (DR) was controversial. Therefore, we performed a meta-analysis to evaluate the relationship between
diabetic retinopathy 5061 “hypercholesterolemia” or “lipids” or “lipoprotein” or “triglyceride” or “hyperlipidemia”) and DR (“ diabetic retinopathy ”) were combined to identify the relevant studies. A manual retrieval of the reference lists was also
diabetic retinopathy 10713 differences in TG levels between patients with DR and without DR. CI = confidence interval, DR = diabetic retinopathy , SD = standard deviation.Figure 3The differences in TC levels between patients with DR and without
diabetic retinopathy 10880 differences in TC levels between patients with DR and without DR. CI = confidence interval, DR = diabetic retinopathy , SD = standard deviation.HDL-C and DR as shown in Fig. 4, 5 studies evaluated the differences in
diabetic retinopathy 11621 differences in HDL-C levels between patients with DR and without DR. CI = confidence interval, DR = diabetic retinopathy , HDL-C = high-density lipoprotein cholesterol, SD = standard deviation.LDL-C and DR as shown
diabetic retinopathy 12542 differences in LDL-C levels between patients with DR and without DR. CI = confidence interval, DR = diabetic retinopathy , LDL-C = low-density lipoprotein cholesterol, SD = standard deviation.Discussion4Decades ago,
hyperglycemia 2502 increasing morbidity of DM, worldwide prevalence of DR was expected to increase to 5.4% by 2025. Although hyperglycemia was a classical risk factor for DR, better glucose control was reported to have an unsatisfactory effect
hyperlipidemia 5031 “cholesterol” or “hypercholesterolemia” or “lipids” or “lipoprotein” or “triglyceride” or “ hyperlipidemia ”) and DR (“diabetic retinopathy”) were combined to identify the relevant studies. A manual retrieval
hyperlipidemia 14733 macular edema (DME). Although DME was always an indicator of server stages of DR, we thought the role of hyperlipidemia involved in DR and DME might be different to some extent. As previously demonstrated, for DME, it was

You must be authorized to submit a review.